Skip to main content

Want a detailed portfolio tracker?

Merus N.V (MRUS) P/E (2019 - 2025)

Merus N.V (MRUS) P/E from Dec 31, 2019 to Dec 30, 2025. The TTM Merus N.V (MRUS) P/E is -17.32. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Merus N.V (MRUS)

YearP/EChange
2025-17.32+33.18%
2024-13.00+73.47%
2023-7.50-31.12%
2022-10.88-42.02%
2021-18.77+206.86%
2020-6.12-61.75%
2019-15.99N/A

Comparison Merus N.V (MRUS) P/E with competitors

Merus N.V (MRUS) P/E is -17.32.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.43%
FGENFibroGen Inc0.24-101.39%
CHRSCoherus Biosciences Inc0.85-104.90%
FBIOFortress Biotech Inc0.95-105.48%
ORMPOramed Pharmaceuticals Inc1.50-108.68%
AGENAgenus Inc3.01-117.38%
INVAInnoviva Inc3.15-118.21%
VXRTVaxart Inc3.55-120.50%
CRMDCorMedix Inc3.63-120.95%
CVACCureVac N.V.4.45-125.67%
GLPGGalapagos NV4.86-128.06%
SRPTSarepta Therapeutics Inc4.88-128.19%
ABEOAbeona Therapeutics Inc5.39-131.11%
ABUSArbutus Biopharma Corp5.60-132.31%
ZVRAZevra Therapeutics Inc5.89-133.99%
SPROSpero Therapeutics Inc6.23-135.97%
CGENCompugen Ltd6.31-136.46%
RIGLRigel Pharmaceuticals6.87-139.68%
SLXNSilexion Therapeutics Corp7.30-142.13%
OMEROmeros Corporation9.26-153.46%
AUPHAurinia Pharmaceuticals Inc9.58-155.35%
PLXProtalix BioTherapeutics Inc10.89-162.89%
ACADAcadia Pharmaceuticals Inc11.73-167.72%
TBPHTheravance Biopharma Inc12.26-170.81%
ADMAAdma Biologics Inc12.42-171.71%
HRMYHarmony Biosciences Holdings Inc13.82-179.80%
SABSSAB Biotherapeutics Inc14.14-181.63%
NAGENiagen Bioscience Inc14.82-185.56%
INCYIncyte Corp15.82-191.36%
REGNRegeneron Pharmaceuticals Inc15.86-191.56%
PBYIPuma Biotechnology Inc17.32-199.99%
CPRXCatalyst Pharmaceuticals Inc17.44-200.70%
EXELExelixis Inc17.54-201.27%
TGTXTG Therapeutics Inc18.97-209.52%
MDXGMimedx Group Inc20.55-218.68%
XOMAXOMA Royalty Corp22.87-232.09%
ARGXArgen X SE24.30-240.31%
CTMXCytomX Therapeutics Inc24.82-243.33%
XOMAOXOMA Royalty Corp25.34-246.35%
HALOHalozyme Therapeutics Inc25.62-247.96%
XOMAPXOMA Royalty Corp25.67-248.23%
VRTXVertex Pharmaceuticals Inc27.99-261.66%
RPRXRoyalty Pharma plc - Class A28.69-265.66%
SLNOSoleno Therapeutics Inc29.02-267.55%
ASNDAscendis Pharma A/S30.09-273.73%
LGNDLigand Pharmaceuticals Inc - Class B37.91-318.92%
APLSApellis Pharmaceuticals Inc39.02-325.33%
BMRNBiomarin Pharmaceutical Inc42.21-343.75%
KRYSKrystal Biotech Inc45.34-361.84%
ONCBeiGene Ltd69.54-501.56%
PHARPharming Group N.V.75.03-533.24%
TECHBio-Techne Corp101.96-688.76%
VCELVericel Corp109.92-734.74%
ALNYAlnylam Pharmaceuticals Inc117.96-781.19%
GMABGenmab140.29-910.11%
TLXTelix Pharmaceuticals Ltd162.15-1036.35%
CORTCorcept Therapeutics Inc212.86-1329.15%